Stocks closed mixed on Wall Street Tuesday as gains from a handful of Big Tech companies were tempered by weakness elsewhere in the market.
Treasury yields fell, which hurt banks but helped tech companies. The S&P 500 rose 0.3%, notching another record high. The Dow Jones Industrial Average slipped 0.2% and the tech-heavy Nasdaq rose 1.1%. Among major tech stocks, Apple gained 2.4%. Johnson & Johnson fell 1.3% after U.S. regulators recommended a pause in using its single-dose COVID-19 vaccine to investigate reports of possibly dangerous blood clots.
On Tuesday:
The S&P 500 rose 13.60 points, or 0.3%, to 4,141.59.
The Dow Jones Industrial Average fell 68.13 points, or 0.2%, to 33,677.27.
The Nasdaq rose 146.10 points, or 1.1%, to 13,996.10.
The Russell 2000 index of smaller companies fell 4.86 points, or 0.2% to 2,228.92.
For the week:
The S&P 500 is up 12.79 points, or 0.3%.
The Dow is down 123.33 points, or 0.4%.
The Nasdaq is up 95.91 points, or 0.7%.
The Russell 2000 is down 14.55 points, or 0.6%.
For the year:
The S&P 500 is up 385.52 points, or 10.3%.
The Dow is up 3,070.79 points, or 10%.
The Nasdaq is up 1,107.82 points, or 8.6%.
The Russell 2000 is up 254.07 points, or 12.9%.
Before you consider Johnson & Johnson, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson & Johnson wasn't on the list.
While Johnson & Johnson currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report